UNCY Unicycive Therapeutics, Inc.

Fundamentals / CIK 0001766140 / USD

Unicycive Therapeutics, Inc. reported $69.93M in total assets and a net loss of $36.21M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open UNCY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$4.82M$2.41M$0-$34.42MFY 2020 Net Income: -$2.26M2020FY 2021 Net Income: -$10.02M2021FY 2022 Revenue: $951KFY 2022 Net Income: -$18.06M2022FY 2023 Revenue: $675KFY 2023 Net Income: -$30.54M2023FY 2024 Net Income: -$36.73M2024FY 2025 Net Income: -$26.55M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- $675K $951K -- --
Research & Development $9.12M $20.01M $12.90M $12.44M $6.08M $1.01M
Selling, General & Admin -- -- -- $383K $245K $58K
Total Operating Expenses $29.52M $32.12M $21.45M $19.00M $8.98M $2.02M
Operating Income -$29.52M -$32.12M -$20.77M -$18.05M -$8.98M -$2.02M
EBITDA -$29.48M -$32.09M -$20.77M -$17.62M -$8.51M -$1.96M
Interest Income $1.01M $1.26M $615K -- -- --
Interest Expense $71K $71K $82K $6.0K $628K $244K
Net Income -$26.55M -$36.73M -$30.54M -$18.06M -$10.02M -$2.26M
Basic EPS -$1.67 -$5.65 -$12.80 -$12.00 -$8.60 -$2.70
Diluted EPS -$1.67 -$5.65 -$12.80 -$12.00 -$8.60 --
Basic Shares Outstanding 15.9M 6.7M 2.5M 1.5M 1.2M 850.0K
Diluted Shares Outstanding 15.9M 6.7M 2.5M 1.5M 1.2M --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $2.25M $2.79M $1.61M $2.25M $2.96M $1.75M $2.17M $5.29M
Total Operating Expenses $8.84M $10.14M $8.44M $7.22M $7.34M $6.96M $7.99M $9.26M
Operating Income -$8.84M -$10.14M -$8.44M -$7.22M -$7.34M -$6.96M -$7.99M -$9.26M
EBITDA -$8.83M -$10.13M -$8.43M -$7.21M -$7.33M -$6.96M -$7.98M -$9.25M
Interest Income $503K $441K $394K $351K $279K $155K $226K $314K
Interest Expense -- -- -- $27K $15K $13K $15K $20K
Net Income -$7.00M -$1.72M -$12.82M -$14.67M -$6.01M -$6.45M $570K -$21.52M
Basic EPS -$0.25 -$0.06 -$0.54 -- -$0.33 -$0.52 $0.04 --
Diluted EPS -$0.25 -$0.06 -$0.54 -- -$0.33 -$0.52 -$0.50 --
Basic Shares Outstanding 28.3M 26.9M 23.9M -- 18.1M 12.3M 11.7M --
Diluted Shares Outstanding 28.3M 26.9M 23.9M -- 18.1M 12.3M 12.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $29.20M $26.14M $9.70M $455K $16.58M --
Short-Term Investments $12.07M -- -- -- -- --
Cash & Short-Term Investments $41.27M $26.14M $9.70M $455K $16.58M --
Inventory -- -- -- $2.19M $1.83M --
Total Current Assets $48.96M $30.95M $13.40M $2.64M $18.41M $204K
Property, Plant & Equipment, Net $66K $75K $26K $22K $28K --
Total Non-Current Assets $174K $720K $792K $174K $333K $0
Total Assets $49.13M $31.67M $14.19M $2.82M $18.74M $204K
Accounts Payable $383K $1.06M $839K $892K $742K $184K
Other Current Liabilities $82K $92K $18K -- -- --
Total Current Liabilities $18.94M $24.12M $17.53M $3.28M $2.10M $2.88M
Total Non-Current Liabilities $0 $117K $466K $0 $155K $0
Total Liabilities $18.94M $24.24M $18.00M $3.28M $2.26M $2.88M
Total Debt (incl. Leases) $117K $681K $793K $155K $306K --
Common Stock $22K $11K $35K $15K $15K $9.0K
Retained Earnings -$127.8M -$101.3M -$64.54M -$34.00M -$15.94M -$5.92M
Accumulated Other Comp. Income -$1.0K -- -- -- -- --
Total Stockholders' Equity $30.20M $7.43M -$3.81M -$466K $16.48M -$2.67M
Total Equity $30.20M $7.43M -$3.81M -$466K $16.48M -$2.67M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $41.97M $44.19M $37.37M $29.20M $42.70M $22.33M $19.77M $26.14M
Short-Term Investments $17.01M $17.24M $17.21M $12.07M -- -- -- --
Cash & Short-Term Investments $58.97M $61.42M $54.59M $41.27M $42.70M $22.33M $19.77M $26.14M
Total Current Assets $69.16M $71.32M $63.55M $48.96M $50.29M $29.53M $27.35M $30.95M
Property, Plant & Equipment, Net $255K $41K $48K $66K $75K $83K $83K $75K
Total Non-Current Assets $774K $709K $861K $174K $324K $469K $601K $720K
Total Assets $69.93M $72.03M $64.41M $49.13M $50.61M $30.00M $27.95M $31.67M
Accounts Payable $1.03M $2.23M $1.14M $383K $957K $775K $1.40M $1.06M
Other Current Liabilities $113K $67K $126K $82K $240K $67K $146K $92K
Total Current Liabilities $17.31M $18.70M $26.48M $18.94M $13.13M $13.57M $16.68M $24.12M
Total Non-Current Liabilities $0 $55K $217K $0 $0 $0 $0 $117K
Total Liabilities $17.31M $18.76M $26.70M $18.94M $13.13M $13.57M $16.68M $24.24M
Total Debt (incl. Leases) $522K $671K $815K $117K $265K $409K $548K $681K
Common Stock $29K $28K $25K $22K $21K $122K $120K $11K
Retained Earnings -$149.4M -$142.4M -$140.6M -$127.8M -$113.2M -$107.1M -$127.8M -$101.3M
Accumulated Other Comp. Income -$26K -$23K $6.0K -$1.0K -- -- -- --
Total Stockholders' Equity $52.62M $53.27M $37.70M $30.20M $37.48M $16.43M $11.27M $7.43M
Total Equity $52.62M $53.27M $37.70M $30.20M $37.48M $16.43M $11.27M $7.43M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$26.55M -$36.73M -$30.54M -$18.06M -$10.02M -$2.26M
Depreciation & Amortization $34K $22K $9.0K $428K $468K $63K
Stock-Based Compensation $2.64M $2.35M $1.77M $1.05M $966K $232K
Operating Cash Flow -$31.32M -$28.57M -$18.28M -$15.65M -$5.77M -$1.46M
Capital Expenditure -$24K -$72K -$12K -$2.0K -$29K --
Free Cash Flow -$31.34M -$28.65M -$18.30M -$15.65M -$5.80M --
Purchases of Investments -$12.07M -- -- -- -- --
Investing Cash Flow -$12.10M -$72K -$12K -$2.0K -$29K --
Common Stock Issued -- -- -- $11K -- --
Dividends Paid -- -$1.09M -$900K -- -- --
Financing Cash Flow $46.47M $45.09M $27.54M -$471K $22.38M $1.44M
Net Change in Cash $3.06M $16.44M $9.25M -$16.12M $16.58M -$15K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.00M -$1.72M -$12.82M -$14.67M -$6.01M -$6.45M $570K -$21.52M
Depreciation & Amortization $7.0K $6.0K $8.0K $10K $10K $6.0K $8.0K $7.0K
Stock-Based Compensation $1.80M $2.88M $754K $777K $730K $571K $563K $582K
Operating Cash Flow -$7.25M -$7.60M -$6.24M -$8.03M -$5.96M -$8.42M -$8.90M -$6.55M
Capital Expenditure -$221K $1.0K -$8.0K $0 -$2.0K -$6.0K -$16K -$22K
Free Cash Flow -$7.47M -$7.60M -$6.25M -$8.03M -$5.96M -$8.43M -$8.92M -$6.57M
Purchases of Investments -$4.16M -$3.00M -$5.15M -- -- -- -- --
Investing Cash Flow $63K -$23K -$5.16M -$12.07M -$2.0K -$6.0K -$16K -$22K
Financing Cash Flow $4.97M $14.44M $19.57M $6.61M $26.33M $10.98M $2.55M $365K
Net Change in Cash -$2.22M $6.81M $8.17M -$13.50M $20.37M $2.56M -$6.37M -$6.21M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -3077.6% -1898.2% -- --
Net Profit Margin -- -- -4525.0% -1898.8% -- --
Return on Equity (ROE) -87.9% -494.3% -- -- -60.8% --
Return on Assets (ROA) -54.0% -116.0% -215.2% -640.8% -53.4% -1109.8%
Current Ratio 2.59x 1.28x 0.76x 0.81x 8.75x 0.07x
Quick Ratio 2.18x 1.08x 0.55x 0.14x 7.88x --
Debt to Equity 0.00x 0.09x -- -- 0.02x --
Revenue Growth (YoY) -- -- -29.0% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -68.8% -66.1% -106.0% -87.9% -89.1% -191.7% -134.8% -494.3%
Return on Assets (ROA) -51.8% -48.9% -62.0% -54.0% -66.0% -105.0% -54.4% -116.0%
Current Ratio 4.00x 3.81x 2.40x 2.59x 3.83x 2.18x 1.64x 1.28x
Quick Ratio 3.41x 3.28x 2.06x 2.18x 3.25x 1.65x 1.19x 1.08x
Debt to Equity 0.01x 0.01x 0.02x 0.00x 0.01x 0.02x 0.05x 0.09x
Net Income Growth (YoY) -- -- -2349.6% -- -- -165.4% -- --
EPS Growth (YoY) -- -- -1450.0% -- -- -165.0% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001766140) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal